NO20000823L - Et middel for Õ fremme sekresjon av veksthormon - Google Patents
Et middel for Õ fremme sekresjon av veksthormonInfo
- Publication number
- NO20000823L NO20000823L NO20000823A NO20000823A NO20000823L NO 20000823 L NO20000823 L NO 20000823L NO 20000823 A NO20000823 A NO 20000823A NO 20000823 A NO20000823 A NO 20000823A NO 20000823 L NO20000823 L NO 20000823L
- Authority
- NO
- Norway
- Prior art keywords
- growth hormone
- promote secretion
- secretion
- promote
- hormone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/42—Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5614297P | 1997-08-19 | 1997-08-19 | |
| PCT/US1998/017229 WO1999008699A1 (en) | 1997-08-19 | 1998-08-19 | Growth hormone secretagogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20000823D0 NO20000823D0 (no) | 2000-02-18 |
| NO20000823L true NO20000823L (no) | 2000-04-12 |
Family
ID=22002443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000823A NO20000823L (no) | 1997-08-19 | 2000-02-18 | Et middel for Õ fremme sekresjon av veksthormon |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0933365A3 (hu) |
| JP (1) | JP2001515046A (hu) |
| KR (1) | KR20010027947A (hu) |
| CN (1) | CN1243567C (hu) |
| AR (1) | AR018010A1 (hu) |
| AU (1) | AU738204B2 (hu) |
| BR (1) | BR9811948A (hu) |
| CA (1) | CA2302467A1 (hu) |
| CO (1) | CO5121066A1 (hu) |
| EA (1) | EA002746B1 (hu) |
| HR (1) | HRP20000090A2 (hu) |
| HU (1) | HUP0002392A3 (hu) |
| ID (1) | ID25000A (hu) |
| IL (1) | IL134596A0 (hu) |
| MY (1) | MY138258A (hu) |
| NO (1) | NO20000823L (hu) |
| NZ (1) | NZ502947A (hu) |
| PE (1) | PE115999A1 (hu) |
| PL (1) | PL338883A1 (hu) |
| TR (1) | TR200000930T2 (hu) |
| TW (1) | TW577879B (hu) |
| UA (1) | UA58472C2 (hu) |
| WO (1) | WO1999008699A1 (hu) |
| ZA (1) | ZA987385B (hu) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6639076B1 (en) | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
| AU2686899A (en) * | 1998-08-18 | 2000-03-14 | Eli Lilly And Company | Growth hormone secretagogues |
| US6828331B1 (en) | 1999-02-19 | 2004-12-07 | Eli Lilly And Company | Growth hormone secretagogues |
| CO5160260A1 (es) * | 1999-02-19 | 2002-05-30 | Lilly Co Eli | Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido |
| US6417397B1 (en) | 1999-10-04 | 2002-07-09 | The Regents Of The University Of California, San Diego | N-substituted alkylamino acids for use as amino-protecting groups |
| EP1289526A4 (en) | 2000-05-30 | 2005-03-16 | Merck & Co Inc | MELANOCORTIN RECEPTOR AGONISTS |
| GT200100147A (es) * | 2000-07-31 | 2002-06-25 | Derivados de imidazol | |
| US6756385B2 (en) * | 2000-07-31 | 2004-06-29 | Pfizer Inc. | Imidazole derivatives |
| AU2001294532A1 (en) * | 2000-10-13 | 2002-04-29 | Eli Lilly And Company | Resolution process for preparation of substantially pure (r) and (s) enantiomersof 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof |
| US7125840B2 (en) | 2001-10-09 | 2006-10-24 | Eli Lilly And Company | Substituted dipeptides as growth hormone secretagogues |
| DE60306636T2 (de) | 2002-04-09 | 2007-07-05 | Eli Lilly And Co., Indianapolis | Wachstumhormonsekretionsförderer |
| US7365082B2 (en) * | 2002-12-18 | 2008-04-29 | Bayer Cropscience Ag | N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| CN1934091B (zh) | 2004-03-23 | 2012-02-08 | 辉瑞产品公司 | 治疗神经变性障碍的咪唑化合物 |
| JP2009508934A (ja) | 2005-09-22 | 2009-03-05 | ファイザー・プロダクツ・インク | 神経障害治療のためのイミダゾール化合物 |
| US7601844B2 (en) | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
| US7615556B2 (en) | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
| ES2602789T3 (es) | 2007-02-09 | 2017-02-22 | Ocera Therapeutics, Inc. | Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina |
| TWI433838B (zh) | 2008-06-25 | 2014-04-11 | 必治妥美雅史谷比公司 | 作為趨化因子受體活性調節劑之六氫吡啶衍生物 |
| US8642622B2 (en) | 2010-06-16 | 2014-02-04 | Bristol-Myers Squibb Company | Piperidinyl compound as a modulator of chemokine receptor activity |
| US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
| JP2015525202A (ja) | 2012-05-03 | 2015-09-03 | ノバルティス アーゲー | グレリン受容体アゴニストとしての２，７−ジアザ−スピロ［４，５］デカ−７−イル誘導体のｌ−リンゴ酸塩およびその結晶形態 |
| PL3022202T3 (pl) | 2013-07-18 | 2019-10-31 | Novartis Ag | Inhibitory autotaksyny zawierające heteroaromatyczny rdzeń pierścienia benzylowego - cyklicznego amidu |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| RU2692774C2 (ru) | 2014-08-29 | 2019-06-27 | Дайсел Корпорэйшн | Имидазольное соединение, жидкость для обработки металлической поверхности, способ обработки металлической поверхности и способ изготовления ламината |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| CN107286041A (zh) * | 2016-04-01 | 2017-10-24 | 成都川科化工有限公司 | 一种n,n-二乙基甲酰胺的制备方法 |
| CN108299218A (zh) * | 2017-01-12 | 2018-07-20 | 南京红杉生物科技有限公司 | 一种4-溴-d-苯丙氨酸的合成方法 |
| CN110128285B (zh) * | 2019-06-24 | 2022-03-01 | 华北制药股份有限公司 | D-苯甘氨酸甲酯盐酸盐/d-二氢苯基甘氨酸甲酯盐酸盐的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
| WO1994013696A1 (en) * | 1992-12-11 | 1994-06-23 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
| PL314003A1 (en) * | 1993-10-19 | 1996-08-05 | Merck & Co Inc | Combination of bisulphonates and substances enhancing secretion of growth hormone |
| US5492916A (en) * | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
| ZA966891B (en) * | 1995-08-21 | 1998-02-16 | Lilly Co Eli | 2-acylaminopropanamines as growth hormone secretagogues. |
| WO1997006803A1 (en) * | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamides as growth hormone secretagogues |
-
1998
- 1998-08-17 ZA ZA9807385A patent/ZA987385B/xx unknown
- 1998-08-18 MY MYPI98003772A patent/MY138258A/en unknown
- 1998-08-18 CO CO98047011A patent/CO5121066A1/es unknown
- 1998-08-18 TW TW087113593A patent/TW577879B/zh not_active IP Right Cessation
- 1998-08-18 AR ARP980104068A patent/AR018010A1/es unknown
- 1998-08-18 EP EP98306622A patent/EP0933365A3/en not_active Withdrawn
- 1998-08-19 NZ NZ502947A patent/NZ502947A/en unknown
- 1998-08-19 CA CA002302467A patent/CA2302467A1/en not_active Abandoned
- 1998-08-19 AU AU90256/98A patent/AU738204B2/en not_active Ceased
- 1998-08-19 EA EA200000239A patent/EA002746B1/ru not_active IP Right Cessation
- 1998-08-19 PE PE1998000748A patent/PE115999A1/es not_active Application Discontinuation
- 1998-08-19 IL IL13459698A patent/IL134596A0/xx unknown
- 1998-08-19 UA UA2000020987A patent/UA58472C2/uk unknown
- 1998-08-19 CN CNB988102390A patent/CN1243567C/zh not_active Expired - Fee Related
- 1998-08-19 KR KR1020007001645A patent/KR20010027947A/ko not_active Application Discontinuation
- 1998-08-19 WO PCT/US1998/017229 patent/WO1999008699A1/en active Search and Examination
- 1998-08-19 BR BR9811948-6A patent/BR9811948A/pt not_active IP Right Cessation
- 1998-08-19 JP JP2000509436A patent/JP2001515046A/ja active Pending
- 1998-08-19 ID IDW20000306A patent/ID25000A/id unknown
- 1998-08-19 PL PL98338883A patent/PL338883A1/xx unknown
- 1998-08-19 TR TR2000/00930T patent/TR200000930T2/xx unknown
- 1998-08-19 HU HU0002392A patent/HUP0002392A3/hu unknown
-
2000
- 2000-02-17 HR HR20000090A patent/HRP20000090A2/hr not_active Application Discontinuation
- 2000-02-18 NO NO20000823A patent/NO20000823L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY138258A (en) | 2009-05-29 |
| CO5121066A1 (es) | 2002-01-30 |
| CN1276727A (zh) | 2000-12-13 |
| KR20010027947A (ko) | 2001-04-06 |
| HRP20000090A2 (en) | 2001-04-30 |
| NO20000823D0 (no) | 2000-02-18 |
| TW577879B (en) | 2004-03-01 |
| AR018010A1 (es) | 2001-10-31 |
| NZ502947A (en) | 2001-11-30 |
| AU738204B2 (en) | 2001-09-13 |
| CA2302467A1 (en) | 1999-02-25 |
| AU9025698A (en) | 1999-03-08 |
| ZA987385B (en) | 2000-04-18 |
| HUP0002392A3 (en) | 2000-11-28 |
| HUP0002392A2 (hu) | 2000-10-28 |
| EP0933365A3 (en) | 2003-03-19 |
| JP2001515046A (ja) | 2001-09-18 |
| PE115999A1 (es) | 1999-11-26 |
| CN1243567C (zh) | 2006-03-01 |
| BR9811948A (pt) | 2000-08-22 |
| TR200000930T2 (tr) | 2000-11-21 |
| IL134596A0 (en) | 2001-04-30 |
| UA58472C2 (uk) | 2003-08-15 |
| PL338883A1 (en) | 2000-11-20 |
| EA002746B1 (ru) | 2002-08-29 |
| EP0933365A2 (en) | 1999-08-04 |
| EA200000239A1 (ru) | 2000-10-30 |
| ID25000A (id) | 2000-09-07 |
| WO1999008699A1 (en) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000823L (no) | Et middel for Õ fremme sekresjon av veksthormon | |
| DK0869968T3 (da) | Væksthormonsecerneringsfremmende stof | |
| DE69837264D1 (de) | Dipeptidderivate zur förderung der sekretion von wachstumshormon | |
| NO996469L (no) | Tartratsalt av et substituert dipeptid som et veksthormonutskillelsesmiddel | |
| CY2012029I1 (el) | Νεα μορφη της s-ομεπραζολης | |
| IS1901B (is) | Efnasambönd til að hindra magasýruseytrun | |
| DK1289951T3 (da) | Væksthormon sekretionsfremmere | |
| DE69714582T2 (de) | Katheter zur lokalen verabreichung einer therapeutisch aktiven substanz | |
| ATE375996T1 (de) | Sekretionsfordermittel fur wachtumshormon | |
| FI921059A0 (fi) | Menetelmä hyötyproteiinien erittämiseksi hiivoista | |
| FR2794169B1 (fr) | Procede de controle de la capacite de fonctionnement d'un pot catalytique | |
| NO20002149D0 (no) | FremgangsmÕte for Õ redusere avhengighet hos pattedyr | |
| DE69933057D1 (de) | Analoge des humanen basischen fibroblasten-wachstumsfactors | |
| FI940511A (fi) | Menetelmä ferrisulfaatin valmistamiseksi | |
| ID24861A (id) | Proses untuk membuat perangsang sekresi hormon pertumbuhan | |
| DE69612084T2 (de) | Wachstumsfaktor-Analoga | |
| NO20010828L (no) | Tidsforskyvningsteknikk for Õ øke kapasiteten i et kommunikasjonssystem av kategori CDMA | |
| FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
| FI972362A (fi) | Tulehduksenvastainen aine ulkoiseen käyttöön | |
| FI970329A (fi) | Menetelmä suodattimen tukkeutumisen estämiseksi | |
| FI863168A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivista dihydrobentso/b/tiofeenia | |
| ZA200000771B (en) | Homeopathic preparations of purified growth hormone. | |
| DK1226125T3 (da) | Fremgangsmåde til fremstilling af mavesårsmidler | |
| EE200100562A (et) | Meetod sidesüsteemi uute teenuste lisamise hõlbustamiseks | |
| BR1101007A (pt) | Compostos de polipetìdeo contendo d-2-alquiltriptofan capazes de promover a liberação de hormÈnio de crescimento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |